Gevaert Gevaert P P Mepolizumab, a humanized anti-IL-5 mAb, as a treatment option for severe nasal polyposis Mepolizumab, a humanized anti-IL-5 mAb, as a treatment option for severe nasal polyposis J Allergy Clin Immunol J Allergy Clin Immunol 2011 2011 128 128 989 989 995.e1-8 995.e1-8 10.1016/j.jaci.2011.07.056 10.1016/j.jaci.2011.07.056 supplied-pmid 21958585? This evidence concerns the gene IL5 and Nasal polyposis.